Advisors

RiverVest Venture Partners® has accomplished scientific and industry advisors to provide guidance on industry trends and the latest in medical research. These individuals bring to RiverVest life science experience ranging from academic research and startup activities to senior leadership roles in the medical device and pharmaceutical industries, as well as academia.

Michael Berman

• Co-founder and member of the Board of Directors of Velocimed and Aetherworks.
  
• Chairman of Curon, board member of CoAxia, Myocor, Nugyn, Transoma Medical and TopSpin Medical.
  
• Former vice president of marketing and first product manager, Scimed, where revenue grew from zero to $300 million prior to Boston Scientific’s acquisition, then to $1.5 billion while President of Boston Scientific/Scimed.
  
• Former senior vice president of Boston Scientific, member of the Executive Committee and Group President of the Cardiology Businesses and President of Boston Scientific/Scimed.

Floyd E. Bloom, M.D.

• Chairman and professor, Department of Neuropharmacology, Scripps Research Institute, chief executive officer, Neurome, Inc. and founder and director, Alkermes Corporation.
  
• Member of the Scientific Advisory Boards of Glaxo/SmithKline, Neogene and Digital Gene Technology.
  
• Former editor in chief, Science. Member and former chairman, Neurobiology Section of the National Academy of Sciences.
  
• Chairman, National Council, Washington University in St. Louis School of Medicine.

Joseph M. Davie, M.D., Ph.D.

• Former senior vice president, Department of Research, Biogen, Inc., corporate senior vice president, science and technology, G.D. Searle and professor and department head of Microbiology and Immunology, Washington University in St. Louis School of Medicine.
  
• Board member of Auxeris Therapeutics, Inc., Beyond Genomics, Curis, Inc., Inflazyme Pharmaceuticals, Ltd., Keel Pharmaceuticals, Inc., Metaphore Pharmaceuticals, Inc., Neogensesis, Inc., Stratatech, LLC, and Targeted Genetics, Inc.
  
• Member, National Council, Washington University in St. Louis School of Medicine.
  

Nancy J. Hutson, Ph.D

• Former senior vice president of Pfizer Global Research & Development, most recently as Head of Groton/New London Labs (Pfizer’s largest R&D site), and prior to that as Head of Exploratory Development US.
  
• Board member of Inspire Pharmaceuticals and African Medical and Research Foundation US.
  
• Recipient of NIH National Research Service Award, Department of Biochemistry, University of Oxford, and Roslyn S. Yallow Research & Development Award from the American Diabetes Association.
• Member of the American Physiological Society.
• Connecticut Woman of Innovation in Research, Innovation and Leadership, presented by the Connecticut Technology Council, February 2006.
  

William A. Peck, M.D.

• Director of The Center of Health Policy and former executive vice chancellor for medical affairs and dean of the School of Medicine, Washington University in St. Louis.
  
• Board member of Allied Health Care Products, Angelica Corporation, Hologic Corporation, Reinsurance Group of America, and TIAA-CREF Trust Company. Vice-Chairman of Research!America.
  
• Member, Scientific Advisory Committee of Johnson & Johnson and founding president of the National Osteoporosis Foundation.